JP2015510946A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015510946A5 JP2015510946A5 JP2015501862A JP2015501862A JP2015510946A5 JP 2015510946 A5 JP2015510946 A5 JP 2015510946A5 JP 2015501862 A JP2015501862 A JP 2015501862A JP 2015501862 A JP2015501862 A JP 2015501862A JP 2015510946 A5 JP2015510946 A5 JP 2015510946A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- substituted
- group
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 75
- 125000000217 alkyl group Chemical group 0.000 claims 64
- 229910052739 hydrogen Inorganic materials 0.000 claims 52
- 239000001257 hydrogen Substances 0.000 claims 52
- 150000002431 hydrogen Chemical class 0.000 claims 27
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 25
- -1 substituted Chemical class 0.000 claims 23
- 229940024606 amino acid Drugs 0.000 claims 22
- 235000001014 amino acid Nutrition 0.000 claims 22
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 19
- 125000003342 alkenyl group Chemical group 0.000 claims 18
- 125000003107 substituted aryl group Chemical group 0.000 claims 18
- 125000000304 alkynyl group Chemical group 0.000 claims 16
- 150000001413 amino acids Chemical class 0.000 claims 15
- 125000003118 aryl group Chemical group 0.000 claims 14
- 229910052736 halogen Inorganic materials 0.000 claims 13
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 11
- 241000700605 Viruses Species 0.000 claims 10
- 150000002367 halogens Chemical class 0.000 claims 10
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 8
- 229960003767 alanine Drugs 0.000 claims 8
- 235000004279 alanine Nutrition 0.000 claims 8
- 125000001072 heteroaryl group Chemical group 0.000 claims 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims 7
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 6
- 229960004295 valine Drugs 0.000 claims 6
- 239000004474 valine Substances 0.000 claims 6
- 125000001153 fluoro group Chemical group F* 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 5
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 4
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 4
- 239000004471 Glycine Substances 0.000 claims 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 4
- 241001113283 Respirovirus Species 0.000 claims 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims 4
- 229960002449 glycine Drugs 0.000 claims 4
- 229960003136 leucine Drugs 0.000 claims 4
- 229930182817 methionine Natural products 0.000 claims 4
- 229960004452 methionine Drugs 0.000 claims 4
- 229960005190 phenylalanine Drugs 0.000 claims 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 4
- 229960002429 proline Drugs 0.000 claims 4
- 229960004799 tryptophan Drugs 0.000 claims 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 3
- 239000004475 Arginine Substances 0.000 claims 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 3
- 241000035314 Henipavirus Species 0.000 claims 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 3
- 239000004472 Lysine Substances 0.000 claims 3
- 241000351643 Metapneumovirus Species 0.000 claims 3
- 241000712045 Morbillivirus Species 0.000 claims 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 3
- 239000004473 Threonine Substances 0.000 claims 3
- 125000002252 acyl group Chemical group 0.000 claims 3
- 229960003121 arginine Drugs 0.000 claims 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 3
- 229960001230 asparagine Drugs 0.000 claims 3
- 235000009582 asparagine Nutrition 0.000 claims 3
- 229960005261 aspartic acid Drugs 0.000 claims 3
- 235000003704 aspartic acid Nutrition 0.000 claims 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 3
- 229960002433 cysteine Drugs 0.000 claims 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 3
- 235000018417 cysteine Nutrition 0.000 claims 3
- 229960002989 glutamic acid Drugs 0.000 claims 3
- 235000013922 glutamic acid Nutrition 0.000 claims 3
- 239000004220 glutamic acid Substances 0.000 claims 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 3
- 229960002743 glutamine Drugs 0.000 claims 3
- 235000004554 glutamine Nutrition 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 3
- 229960002885 histidine Drugs 0.000 claims 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 3
- 229960000310 isoleucine Drugs 0.000 claims 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 3
- 229960003646 lysine Drugs 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 229960001153 serine Drugs 0.000 claims 3
- 229960002898 threonine Drugs 0.000 claims 3
- 229960004441 tyrosine Drugs 0.000 claims 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 2
- 102220495689 Putative uncharacterized protein FLJ43944_R40A_mutation Human genes 0.000 claims 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical class O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- GCFAUZGWPDYAJN-UHFFFAOYSA-N cyclohexyl 3-phenylprop-2-enoate Chemical compound C=1C=CC=CC=1C=CC(=O)OC1CCCCC1 GCFAUZGWPDYAJN-UHFFFAOYSA-N 0.000 claims 2
- 229940104302 cytosine Drugs 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 125000001188 haloalkyl group Chemical group 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 229910052698 phosphorus Inorganic materials 0.000 claims 2
- 239000011574 phosphorus Substances 0.000 claims 2
- KDESEECZHLTGMH-QMMMGPOBSA-N propan-2-yl (2s)-2-amino-4-methylpentanoate Chemical compound CC(C)C[C@H](N)C(=O)OC(C)C KDESEECZHLTGMH-QMMMGPOBSA-N 0.000 claims 2
- QDQVXVRZVCTVHE-YFKPBYRVSA-N propan-2-yl (2s)-2-aminopropanoate Chemical compound CC(C)OC(=O)[C@H](C)N QDQVXVRZVCTVHE-YFKPBYRVSA-N 0.000 claims 2
- 125000004646 sulfenyl group Chemical group S(*)* 0.000 claims 2
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims 1
- 125000000081 (C5-C8) cycloalkenyl group Chemical group 0.000 claims 1
- RMSGQZDGSZOJMU-UHFFFAOYSA-N 1-butyl-2-phenylbenzene Chemical group CCCCC1=CC=CC=C1C1=CC=CC=C1 RMSGQZDGSZOJMU-UHFFFAOYSA-N 0.000 claims 1
- 241000342334 Human metapneumovirus Species 0.000 claims 1
- 241000726041 Human respirovirus 1 Species 0.000 claims 1
- 241000712003 Human respirovirus 3 Species 0.000 claims 1
- 241001559187 Human rubulavirus 2 Species 0.000 claims 1
- 241001559186 Human rubulavirus 4 Species 0.000 claims 1
- 241000712079 Measles morbillivirus Species 0.000 claims 1
- 241000711386 Mumps virus Species 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000005282 allenyl group Chemical group 0.000 claims 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 102220481543 eIF5-mimic protein 2_R39A_mutation Human genes 0.000 claims 1
- 102220481542 eIF5-mimic protein 2_R41A_mutation Human genes 0.000 claims 1
- 125000004494 ethyl ester group Chemical group 0.000 claims 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 150000004702 methyl esters Chemical class 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 102220596570 tRNA-splicing endonuclease subunit Sen15_R43A_mutation Human genes 0.000 claims 1
- 229940035893 uracil Drugs 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
- 0 C*(C)*CC[n]1c(nc(*)nc2*)c2nc1 Chemical compound C*(C)*CC[n]1c(nc(*)nc2*)c2nc1 0.000 description 1
- XBCXJKGHPABGSD-UHFFFAOYSA-N CN(C=CC(N1)=O)C1=O Chemical compound CN(C=CC(N1)=O)C1=O XBCXJKGHPABGSD-UHFFFAOYSA-N 0.000 description 1
- OXKBOESOCFIGTH-UHFFFAOYSA-N CN1[I]=NC2=C1N=CNC2=O Chemical compound CN1[I]=NC2=C1N=CNC2=O OXKBOESOCFIGTH-UHFFFAOYSA-N 0.000 description 1
- UUWJNBOCAPUTBK-UHFFFAOYSA-N C[n]1c(N=C(N)NC2=O)c2nc1 Chemical compound C[n]1c(N=C(N)NC2=O)c2nc1 UUWJNBOCAPUTBK-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261613836P | 2012-03-21 | 2012-03-21 | |
| US61/613,836 | 2012-03-21 | ||
| US13/721,988 | 2012-12-20 | ||
| US13/721,988 US9073960B2 (en) | 2011-12-22 | 2012-12-20 | Substituted nucleosides, nucleotides and analogs thereof |
| PCT/US2013/033018 WO2013142525A1 (en) | 2012-03-21 | 2013-03-19 | Substituted nucleosides, nucleotides and analogs thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015510946A JP2015510946A (ja) | 2015-04-13 |
| JP2015510946A5 true JP2015510946A5 (OSRAM) | 2016-05-19 |
| JP6430364B2 JP6430364B2 (ja) | 2018-11-28 |
Family
ID=49223309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015501862A Expired - Fee Related JP6430364B2 (ja) | 2012-03-21 | 2013-03-19 | 置換されたヌクレオシド、ヌクレオチドおよびそのアナログ |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US20190381081A1 (OSRAM) |
| EP (1) | EP2827875B1 (OSRAM) |
| JP (1) | JP6430364B2 (OSRAM) |
| KR (1) | KR102172040B1 (OSRAM) |
| CN (2) | CN110917205A (OSRAM) |
| AP (1) | AP2014007943A0 (OSRAM) |
| AU (2) | AU2013235220C1 (OSRAM) |
| CA (1) | CA2866901C (OSRAM) |
| CL (1) | CL2014002392A1 (OSRAM) |
| CY (1) | CY1122125T1 (OSRAM) |
| DK (1) | DK2827875T3 (OSRAM) |
| EA (1) | EA035159B1 (OSRAM) |
| ES (1) | ES2710506T3 (OSRAM) |
| GE (1) | GEP201706721B (OSRAM) |
| HK (1) | HK1203142A1 (OSRAM) |
| HR (1) | HRP20182030T1 (OSRAM) |
| HU (1) | HUE043054T2 (OSRAM) |
| IL (1) | IL234546B (OSRAM) |
| LT (1) | LT2827875T (OSRAM) |
| ME (1) | ME03502B (OSRAM) |
| MX (2) | MX361460B (OSRAM) |
| NZ (1) | NZ629428A (OSRAM) |
| PH (1) | PH12014502094B1 (OSRAM) |
| PL (1) | PL2827875T3 (OSRAM) |
| PT (1) | PT2827875T (OSRAM) |
| RS (1) | RS58437B1 (OSRAM) |
| SG (2) | SG11201405351RA (OSRAM) |
| SI (1) | SI2827875T1 (OSRAM) |
| SM (1) | SMT201900070T1 (OSRAM) |
| TW (2) | TWI663978B (OSRAM) |
| UA (1) | UA113980C2 (OSRAM) |
| WO (1) | WO2013142525A1 (OSRAM) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105061534A (zh) | 2010-09-22 | 2015-11-18 | 艾丽奥斯生物制药有限公司 | 取代的核苷酸类似物 |
| CA2812962C (en) | 2010-09-22 | 2020-03-31 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
| US8772474B2 (en) | 2010-12-22 | 2014-07-08 | Alios Biopharma, Inc. | Cyclic nucleotide analogs |
| SMT201800662T1 (it) | 2011-12-22 | 2019-01-11 | Alios Biopharma Inc | Nucleotidi, nucleosidi sostituiti e loro analoghi |
| HK1203075A1 (en) | 2011-12-22 | 2015-10-16 | 艾丽奥斯生物制药有限公司 | Substituted phosphorothioate nucleotide analogs |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| HK1203513A1 (en) | 2012-03-21 | 2015-10-30 | 艾丽奥斯生物制药有限公司 | Methods of preparing substituted nucleotide analogs |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| EP2828277A1 (en) | 2012-03-21 | 2015-01-28 | Vertex Pharmaceuticals Incorporated | Solid forms of a thiophosphoramidate nucleotide prodrug |
| WO2013142157A1 (en) | 2012-03-22 | 2013-09-26 | Alios Biopharma, Inc. | Pharmaceutical combinations comprising a thionucleotide analog |
| PL2861611T3 (pl) | 2012-05-25 | 2017-08-31 | Janssen Sciences Ireland Uc | Nukleozydy uracylowe spirooksetanu |
| CA2890359A1 (en) | 2012-11-07 | 2014-05-15 | Zucai SUO | Substituted gemcitabine aryl amide analogs and treatment methods using same |
| WO2014100498A1 (en) | 2012-12-21 | 2014-06-26 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| EP3912984A1 (en) | 2012-12-21 | 2021-11-24 | Janssen BioPharma, Inc. | 4'-fluoro-nucleosides, 4'-fluoro-nucleotides and analogs thereof for the treatment of hcv |
| CA2908313A1 (en) | 2013-04-05 | 2014-10-09 | Alios Biopharma, Inc. | Hepatitis c viral infection treatment using a combination of compounds |
| EP3424938B1 (en) | 2013-06-26 | 2020-07-22 | Janssen BioPharma, Inc. | 4'-azidoalkyl-substituted nucleosides, nucleotides and analogs thereof |
| EP3013340B9 (en) | 2013-06-26 | 2023-10-04 | Janssen Pharmaceuticals, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| SG10201804835VA (en) * | 2013-10-11 | 2018-07-30 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| WO2015106128A2 (en) | 2014-01-09 | 2015-07-16 | Alnylam Pharmaceuticals, Inc. | MODIFIED RNAi AGENTS |
| JP6581100B2 (ja) * | 2014-02-06 | 2019-09-25 | リボサイエンス・エルエルシー | インフルエンザｒｎａ複製の阻害剤としての４’−ジフルオロメチル置換ヌクレオシド誘導体 |
| CN106459130A (zh) * | 2014-03-03 | 2017-02-22 | 纽科利制药公司 | 吉西他滨类似物 |
| CN106573011A (zh) * | 2014-06-24 | 2017-04-19 | 艾丽奥斯生物制药有限公司 | 取代的核苷、核苷酸和其类似物 |
| TN2016000566A1 (en) | 2014-06-24 | 2018-04-04 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| MA40403A (fr) * | 2014-07-22 | 2017-05-31 | Alios Biopharma Inc | Méthodes de traitement de paramyxovirus |
| TWI678369B (zh) | 2014-07-28 | 2019-12-01 | 美商基利科學股份有限公司 | 用於治療呼吸道合胞病毒感染之噻吩並［３,２-ｄ］嘧啶、呋喃並［３,２-ｄ］嘧啶及吡咯並［３,２-ｄ］嘧啶化合物類 |
| BR112017002332A2 (pt) * | 2014-08-05 | 2017-11-21 | Alios Biopharma Inc | terapia de combinação para o tratamento de um paramixovírus |
| TWI673283B (zh) * | 2014-08-21 | 2019-10-01 | 美商基利科學股份有限公司 | ２’－氯胺基嘧啶酮及嘧啶二酮核苷類 |
| AU2015320511B2 (en) | 2014-09-26 | 2020-11-12 | Riboscience Llc | 4'-vinyl substituted nucleoside derivatives as inhibitors of Respiratory Syncytial Virus RNA replication |
| WO2016069489A1 (en) | 2014-10-28 | 2016-05-06 | Alios Biopharma, Inc. | Methods of preparing substituted nucleoside analogs |
| MA41441A (fr) | 2014-12-19 | 2017-12-12 | Alios Biopharma Inc | Nucléosides substitués, nucléotides et analogues de ceux-ci |
| MA41213A (fr) | 2014-12-19 | 2017-10-24 | Alios Biopharma Inc | Nucléosides substitués, nucléotides et analogues de ceux-ci |
| JP7381190B2 (ja) | 2014-12-26 | 2023-11-15 | エモリー・ユニバーシテイ | Ｎ４－ヒドロキシシチジン及び誘導体並びにそれに関連する抗ウイルス用途 |
| US10208045B2 (en) | 2015-03-11 | 2019-02-19 | Alios Biopharma, Inc. | Aza-pyridone compounds and uses thereof |
| US10202412B2 (en) | 2016-07-08 | 2019-02-12 | Atea Pharmaceuticals, Inc. | β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections |
| US20180117042A1 (en) | 2016-10-27 | 2018-05-03 | Alios Biopharma, Inc. | Methods for treating respiratory syncytial virus infection |
| US10435429B2 (en) | 2017-10-03 | 2019-10-08 | Nucorion Pharmaceuticals, Inc. | 5-fluorouridine monophosphate cyclic triester compounds |
| KR102626210B1 (ko) | 2017-12-07 | 2024-01-18 | 에모리 유니버시티 | N4-하이드록시사이티딘 및 유도체 및 이와 관련된 항-바이러스 용도 |
| EP3752511A4 (en) | 2018-01-10 | 2021-12-29 | Nucorion Pharmaceuticals, Inc. | Phosphor(n)amidatacetal and phosph(on)atalcetal compounds |
| US11427550B2 (en) | 2018-01-19 | 2022-08-30 | Nucorion Pharmaceuticals, Inc. | 5-fluorouracil compounds |
| EP3934760A1 (en) | 2019-03-06 | 2022-01-12 | GlaxoSmithKline Intellectual Property (No.2) Limited | Compounds useful in hiv therapy |
| MX2022000573A (es) | 2019-07-17 | 2022-02-10 | Nucorion Pharmaceuticals Inc | Compuestos ciclicos de desoxirribonucleotido. |
| TWI883391B (zh) | 2020-02-18 | 2025-05-11 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| TWI775313B (zh) | 2020-02-18 | 2022-08-21 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| CN115135383B (zh) | 2020-02-18 | 2024-06-11 | 吉利德科学公司 | 抗病毒化合物 |
| TW202421168A (zh) | 2020-03-20 | 2024-06-01 | 美商基利科學股份有限公司 | 4’-c-經取代-2-鹵基-2’-去氧腺苷核苷之前藥及其製造與使用方法 |
| KR20230004716A (ko) | 2020-04-21 | 2023-01-06 | 리간드 파마슈티칼스 인코포레이티드 | 뉴클레오티드 프로드러그 화합물 |
| CN111892636A (zh) * | 2020-08-07 | 2020-11-06 | 山东大学 | 一种阿兹夫定的合成方法 |
| JP7688152B2 (ja) | 2021-04-16 | 2025-06-03 | ギリアード サイエンシーズ， インコーポレイテッド | アミドを使用してカルバヌクレオシドを調製する方法 |
| KR20240049311A (ko) | 2021-08-18 | 2024-04-16 | 길리애드 사이언시즈, 인코포레이티드 | 인지질 화합물 및 이의 제조 및 사용 방법 |
| JP2025509635A (ja) * | 2022-03-15 | 2025-04-11 | ローム・セラピューティクス・インコーポレイテッド | 疾患を治療するための化合物及び方法 |
| WO2024103016A1 (en) * | 2022-11-11 | 2024-05-16 | Rome Therapeutics, Inc. | 4'-halomethyl-cytidine phosphoramidates and related compounds and their use in treating medical conditions |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5432272A (en) | 1990-10-09 | 1995-07-11 | Benner; Steven A. | Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases |
| JP4076114B2 (ja) * | 1999-05-12 | 2008-04-16 | ヤマサ醤油株式会社 | ４’−ｃ−エチニルプリンヌクレオシド化合物 |
| KR20090089922A (ko) * | 2000-10-18 | 2009-08-24 | 파마셋 인코포레이티드 | 바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드 |
| SI1355916T1 (sl) | 2001-01-22 | 2007-04-30 | Merck & Co Inc | Nukleozidni derivati kot inhibitorji RNA-odvisne RNA virusne polimeraze |
| EP1572705A2 (en) * | 2002-01-17 | 2005-09-14 | Ribapharm, Inc. | Sugar modified nucleosides as viral replication inhibitors |
| JP2005525358A (ja) * | 2002-02-28 | 2005-08-25 | ビオタ インコーポレーティッド | ヌクレオチド模倣体およびそのプロドラッグ |
| CN100532388C (zh) * | 2007-07-16 | 2009-08-26 | 郑州大学 | 2’-氟-4’-取代-核苷类似物、其制备方法及应用 |
| WO2009125841A1 (ja) * | 2008-04-10 | 2009-10-15 | 浜理薬品工業株式会社 | ５－メチルウリジンを出発原料とするエチニルチミジン化合物の製造方法 |
| GB0815968D0 (en) * | 2008-09-03 | 2008-10-08 | Angeletti P Ist Richerche Bio | Antiviral agents |
| US8163707B2 (en) * | 2008-09-15 | 2012-04-24 | Enanta Pharmaceuticals, Inc. | 4′-allene-substituted nucleoside derivatives |
| SG186830A1 (en) * | 2010-07-22 | 2013-02-28 | Gilead Sciences Inc | Methods and compounds for treating paramyxoviridae virus infections |
| CN105061534A (zh) * | 2010-09-22 | 2015-11-18 | 艾丽奥斯生物制药有限公司 | 取代的核苷酸类似物 |
| CA2812962C (en) * | 2010-09-22 | 2020-03-31 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
| SMT201800662T1 (it) * | 2011-12-22 | 2019-01-11 | Alios Biopharma Inc | Nucleotidi, nucleosidi sostituiti e loro analoghi |
| JP6242378B2 (ja) * | 2012-03-13 | 2017-12-06 | ギリアード サイエンシーズ， インコーポレイテッド | 抗ウイルス処置のための２’−置換カルバヌクレオシド類似体 |
-
2013
- 2013-03-19 HU HUE13763460A patent/HUE043054T2/hu unknown
- 2013-03-19 CA CA2866901A patent/CA2866901C/en active Active
- 2013-03-19 PL PL13763460T patent/PL2827875T3/pl unknown
- 2013-03-19 CN CN201911178884.9A patent/CN110917205A/zh active Pending
- 2013-03-19 AU AU2013235220A patent/AU2013235220C1/en not_active Ceased
- 2013-03-19 EA EA201491493A patent/EA035159B1/ru not_active IP Right Cessation
- 2013-03-19 EP EP13763460.6A patent/EP2827875B1/en active Active
- 2013-03-19 ES ES13763460T patent/ES2710506T3/es active Active
- 2013-03-19 AP AP2014007943A patent/AP2014007943A0/xx unknown
- 2013-03-19 PT PT13763460T patent/PT2827875T/pt unknown
- 2013-03-19 RS RS20190171A patent/RS58437B1/sr unknown
- 2013-03-19 LT LTEP13763460.6T patent/LT2827875T/lt unknown
- 2013-03-19 NZ NZ629428A patent/NZ629428A/en not_active IP Right Cessation
- 2013-03-19 ME MEP-2019-36A patent/ME03502B/me unknown
- 2013-03-19 DK DK13763460.6T patent/DK2827875T3/en active
- 2013-03-19 MX MX2014011238A patent/MX361460B/es active IP Right Grant
- 2013-03-19 SG SG11201405351RA patent/SG11201405351RA/en unknown
- 2013-03-19 WO PCT/US2013/033018 patent/WO2013142525A1/en not_active Ceased
- 2013-03-19 CN CN201380015428.7A patent/CN104203253A/zh active Pending
- 2013-03-19 GE GEAP201313603A patent/GEP201706721B/en unknown
- 2013-03-19 SG SG10201804571TA patent/SG10201804571TA/en unknown
- 2013-03-19 HK HK15103627.8A patent/HK1203142A1/xx unknown
- 2013-03-19 UA UAA201411297A patent/UA113980C2/uk unknown
- 2013-03-19 SM SM20190070T patent/SMT201900070T1/it unknown
- 2013-03-19 HR HRP20182030TT patent/HRP20182030T1/hr unknown
- 2013-03-19 SI SI201331282T patent/SI2827875T1/sl unknown
- 2013-03-19 KR KR1020147029092A patent/KR102172040B1/ko not_active Expired - Fee Related
- 2013-03-19 JP JP2015501862A patent/JP6430364B2/ja not_active Expired - Fee Related
- 2013-03-21 TW TW107105463A patent/TWI663978B/zh not_active IP Right Cessation
- 2013-03-21 TW TW102110129A patent/TWI639612B/zh not_active IP Right Cessation
-
2014
- 2014-09-09 IL IL234546A patent/IL234546B/en active IP Right Grant
- 2014-09-10 CL CL2014002392A patent/CL2014002392A1/es unknown
- 2014-09-19 MX MX2018015050A patent/MX2018015050A/es unknown
- 2014-09-22 PH PH12014502094A patent/PH12014502094B1/en unknown
-
2018
- 2018-06-07 AU AU2018204024A patent/AU2018204024A1/en not_active Abandoned
-
2019
- 2019-02-06 CY CY20191100160T patent/CY1122125T1/el unknown
- 2019-06-21 US US16/449,164 patent/US20190381081A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015510946A5 (OSRAM) | ||
| JP2015503506A5 (OSRAM) | ||
| JP2012521359A5 (OSRAM) | ||
| JP2016523906A5 (OSRAM) | ||
| JP2016536288A5 (OSRAM) | ||
| JP2017519784A5 (OSRAM) | ||
| CY1124469T1 (el) | Παραγωγα πυριμιδινης για τη θεραπευτικη αντιμετωπιση ιογενων λοιμωξεων | |
| IL274901B2 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
| JP2013521295A5 (OSRAM) | ||
| NZ629428A (en) | Substituted nucleosides, nucleotides and analogs thereof | |
| EA201291301A1 (ru) | Производные 2-хинолинилуксусной кислоты в качестве противовирусных соединений против вич | |
| AR089408A1 (es) | Nucleosidos sustituidos, nucleotidos y analogos de los mismos para ser empleados en el tratamiento de enfermedades virales | |
| BR112014006840A2 (pt) | derivados de pirrolopirimidina e purina | |
| JP2013537907A5 (OSRAM) | ||
| NZ716822A (en) | Antiviral compounds | |
| SG179445A1 (en) | Nucleoside phosphoramidate prodrugs | |
| SI2906563T1 (en) | Derivatives of pyrrolo (3,2-d) pyrimidine for the treatment of viral infections and other diseases | |
| UA108221C2 (uk) | Похідні тіофен-2-карбонової кислоти як інгібітори вірусів flaviviridae | |
| EA201290053A1 (ru) | Ингибиторы вирусов flaviviridae | |
| NZ627036A (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
| NZ609487A (en) | Indoles as respiratory syncytial virus antiviral agents | |
| JP2012522729A5 (OSRAM) | ||
| EA202090514A1 (ru) | Противовирусное средство против гепатита в | |
| JP2018531941A5 (OSRAM) | ||
| PH12014500988A1 (en) | Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl -4 - yl) - 1h - imidazo - 2 - yl] pyrrolidine - 1 - carbonlymethyl} amine |